Selpercatinib (LOXO-292) in patients with RET-fusion plus non-small-cell lung cancer

Goto, K; Oxnard, G; Tan, DSW; Loong, HHF; Bauer, T; Gainor, J; McCoach, C; Gautschi, O; Besse, B; Cho, BC; Peled, N; Weiss, J; Kim, YJ; Ohe, Y; Horiike, A; Park, K; Huang, X; Olek, E; Subbiah, V; Drilon, A

SWISS MEDICAL WEEKLY, 2020; (): 7S